The FDA Approves IDE for ReGelTec's Pivotal Study of HYDRAFIL® for Chronic Low Back Pain due to Degenerative Disc Disease | News
BALTIMORE--(BUSINESS WIRE)--Sep 28, 2023--
Source: bakersfield.com
Stay updated with breaking news from Regeltec Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BALTIMORE--(BUSINESS WIRE)--Sep 28, 2023--
A Leader in University Academics
This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,...
/PRNewswire/ -- An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back...
Prospect of a potential new treatment for low back pain with preliminary results from an experimental hydrogel injected into degenerated spinal discs